STRATEGIC FUNDING
At BIOSIN Initiative, we manage a funding capacity of over USD 200 million to support projects that drive scientific and technological exchange between China and Europe. Our focus is on advancing high-impact industries such as biotechnology, genetics, human medicine, renewable energy, aerospace engineering, and artificial intelligence.
At the same time, we value diversification: we also consider financing opportunities in other fields including film, entertainment, real estate, and mining, ensuring a balanced and forward-looking portfolio.
Currently, we provide three main types of financing:
​​
1) Direct Investment
We provide capital through direct participation in beneficiary companies, becoming shareholders and ensuring liquidity. In many cases, this support also extends to scientific collaboration and expansion into the Asian market, particularly China. Typically, these companies have a strong credit history, high institutional reputation, and years of proven industry expertise.
​
​
2) Corporate Loans
In this model, BIOSIN Initiative offers liquidity through loans to companies seeking commercial expansion, specialized production, international purchases, or structural improvements. We do not become shareholders or commercial partners; instead, we offer simpler approval processes and more flexible conditions than traditional banks, along with competitive interest rates.
For example, if a European manufacturer of food products requires USD 100,000 to expand operations into another market, BIOSIN Initiative may structure a six-month loan at advantageous terms, providing quick access to growth capital.
​
3) Angel Investment
We also support high-potential projects at their earliest stages, especially in the scientific and technological fields. Seed funding can range from USD 5,000 to USD 2 million, depending on the project’s complexity. Many of these initiatives are led by teams of professionals who may not yet have a legally established company, patents, or a business strategy. BIOSIN Initiative not only provides financial resources but also strategic guidance, helping transform promising ideas into viable, scalable, and profitable ventures across Europe, China, and broader Asia.
​